Global Blood Therapeutics
181 Oyster Point Blvd
South San Francisco
California
94080
United States
Website: http://www.gbt.com/
Email: info@gbt.com
278 articles about Global Blood Therapeutics
-
Check out this article for the impacts that Biotech Bay companies are experiencing due to COVID-19.
-
GBT Announces New Employment Inducement Grants - June 03, 2020
6/3/2020
Global Blood Therapeutics, Inc. announced that on June 1, 2020, the compensation committee of GBT’s board of directors granted seven new employees restricted stock units for an aggregate of 34,000 shares of the company’s common stock.
-
GBT Announces Participation at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast
6/2/2020
Global Blood Therapeutics, Inc. announced that it will present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast on Tuesday, June 9, 2020, at 3:50 p.m. Eastern Time.
-
GBT Announces Upcoming Data Presentations During Virtual Edition of 25th Annual European Hematology Association Congress
5/14/2020
Data include retrospective analysis of landmark STOP 2 Study highlighting correlation between higher hemoglobin levels and lower transcranial Doppler (TCD) flow velocities in children with sickle cell disease SOUTH SAN FRANCISCO, Calif., May 14, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that four abstracts will be presented during the virtual edition of the 25 th Annual European Hematology Association (EHA) Congress taking place June 11-1
-
GBT Announces New Employment Inducement Grants - May 07, 2020
5/7/2020
Global Blood Therapeutics, Inc. announced that on May 1, 2020, the compensation committee of GBT’s board of directors granted seven new employees restricted stock units for an aggregate of 36,500 shares of the company’s common stock.
-
GBT Reports Recent Business Progress and First Quarter 2020 Financial Results
5/6/2020
Global Blood Therapeutics, Inc. reported recent business progress and financial results for the first quarter ended March 31, 2020.
-
GBT to Announce First Quarter 2020 Financial Results on Wednesday, May 6, 2020
4/29/2020
Global Blood Therapeutics, Inc. announced that it will report first quarter 2020 financial results on Wednesday, May 6, 2020, after U.S. financial markets close..
-
GBT Announces New Employment Inducement Grants - April 03, 2020
4/3/2020
Global Blood Therapeutics, Inc. announced that on April 1, 2020, the compensation committee of GBT’s board of directors granted three new employees restricted stock units for an aggregate of 10,550 shares of the company’s common stock.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 3, 2020.
-
GBT Commits $250,000 to Support the Sickle Cell Disease Community During COVID-19 Pandemic
4/2/2020
Newly created GBT Community Fund to provide $150,000 in grants to U.S. non-profits addressing the needs of the sickle cell disease community
-
GBT Takes Steps to Support Public Health Efforts to Address COVID-19 Pandemic
3/17/2020
Global Blood Therapeutics, Inc. announced steps the company is taking to support public health efforts to address the COVID-19 pandemic.
-
GBT Announces New Employment Inducement Grants - March 04, 2020
3/4/2020
Global Blood Therapeutics, Inc. announced that on March 1, 2020, the compensation committee of GBT’s board of directors granted four new employees restricted stock units for an aggregate of 15,550 shares of the company’s common stock.
-
GBT Reports Recent Business Progress and Fourth Quarter and Full Year 2019 Financial Results
2/26/2020
Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today reported recent business progress and financial results for the fourth quarter and year ended December 31, 2019.
-
GBT Announces Participation at the Cowen and Company 40th Annual Healthcare Conference
2/25/2020
Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the Cowen and Company 40th Annual Healthcare Conference in Boston on Tuesday, March 3, 2020, at 12:00 p.m. Eastern Time.
-
Here’s a look at the two drugs that had dates this week but were approved early and are now on the market.
-
GBT Accepting Proposals for 2020 ACCEL Grants to Support Novel Access-to-Care Programs for People Living with Sickle Cell Disease
2/20/2020
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it is accepting proposals for its Access to Excellent Care for Sickle Cell Patients (ACCEL) Grant Program , which provides grant funding to expand novel access-to-care programs for people living with sickle cell disease (SCD). In 2020, the ACCEL program will fund up to five proposals, providing a grant of up to $50,000 each. GBT created the program in 2019 to
-
GBT to Announce Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26, 2020
2/19/2020
Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will report financial results for the fourth quarter and full year ended December 31, 2019, on Wednesday, February 26, 2020, after U.S. financial markets close.
-
GBT Announces New Employment Inducement Grants - Feb. 03, 2020
2/3/2020
Global Blood Therapeutics, Inc. announced that on February 1, 2020, the compensation committee of GBT’s board of directors granted seven new employees options to purchase an aggregate of 16,000 shares of the company’s common stock with a per share exercise price of $65.26 and restricted stock units for an aggregate of 41,450 shares of the company’s common stock.
-
GBT Announces New Employment Inducement Grants - Jan. 08, 2020
1/8/2020
Global Blood Therapeutics, Inc. announced that on January 1, 2020, the compensation committee of GBT’s board of directors granted 7 new employees options to purchase an aggregate of 11,200 shares of the company’s common stock with a per share exercise price of $79.49 and restricted stock units for an aggregate of 24,900 shares of the company’s common stock.
-
GBT to Present at the 38th Annual J.P. Morgan Healthcare Conference
1/7/2020
Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 38th Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2020, at 4:00 p.m. Pacific Time.